Market Overview:

The HERG (Human Ether-à-go-go-Related Gene) Screening Market refers to the testing and screening of drugs for their potential to block the HERG channel, which is a critical ion channel in the human heart that controls the electrical activity responsible for normal heart rhythm. The HERG channel, when blocked, can lead to potentially dangerous cardiac arrhythmias, including a prolonged QT interval, which may cause severe side effects like torsades de pointes. HERG screening is essential during the drug development process to identify compounds that might have cardiotoxic effects. The market includes various technologies such as electrophysiology-based assays, patch-clamp assays, and recombinant cell line assays.

Key players:

Invitae Corporation, Thermo Fisher Scientific, F HoffmannLa Roche Ltd, Siemens Healthineers, Abbott Laboratories, Qiagen, BioRad Laboratories, Danaher Corporation, BD Becton Dickinson and Company, PerkinElmer, Agilent Technologies, Merck KGaA, Illumina, Sysmex Corporation, Quest Diagnostics, Laboratory Corporation of America Holdings LabCorp, BioTechne Corporation, GE Healthcare, Hologic Inc, Myriad Genetics

Sample Link- https://www.trendbridgeinsights.com/industry-report/herg-screening-market

Market segmentation:

Screening Type

• Genetic Screening
• Cancer Screening
• Infectious Disease Screening
• Cardiovascular Screening
• Others

End User

• Hospitals
• Diagnostic Centers
• Research Institutes
• Clinics
• Others

Technology

• Next Generation Sequencing NGS
• Polymerase Chain Reaction PCR
• Immunoassays
• Microarrays
• Others

Application

• Oncology
• Infectious Diseases
• Genetic Disorders
• Cardiovascular Diseases
• Others

Mega Trend Connect:

This report offers deep insights into how mega trends such as digitalization, precision medicine, data-driven care delivery, and regulatory evolution are transforming pharmaceuticals. It further examines the impact of advanced technologies, platform-based models, automation, and interoperability across products and services within this segment. The report assesses regulatory complexity, adoption readiness, cost pressures, and ecosystem maturity shaping global market development.

Global Trade Outlook:

Global trade in pharmaceuticals is increasingly shaped by regulatory stringency, localization mandates, data sovereignty requirements, and public health policy priorities. Cross-border scalability is constrained by approval timelines, compliance variation, and infrastructure readiness, driving regionalized production, partnerships, and delivery models. Market access and competitiveness now depend on regulatory agility, localized execution, and compliance-by-design strategies.

Region Analysis:

The HERG screening market exists across different geographic areas with North America and Europe and Asia-Pacific controlling the majority market share. The North American region stands as the leading market sector because the United States maintains a powerful pharmaceutical industry alongside strict FDA regulations that enforce HERG screening for drug authorization.

Recent Developments:

In March 2025, Charles River Laboratories introduced their next-generation automated HERG screening platform through advanced electrophysiology methods which deliver quick and dependable outcomes.

F&Q:

Q1. What is the projected market size & growth rate of the HERG Screening Market?

HERG Screening Market was valued at USD 2.5 billion in 2024 and is expected to reach to USD 4.3 billion by 2032, growing at a CAGR of 6.8% from 2025 to 2032.

Q2. What are the key driving factors for the growth of the HERG Screening Market?

HERG Screening Market is driven by Improving Knowledge on Cardiotoxicity, Mandatory HERG Screening by Regulatory Agencies, Advancements in Screening Technologies, Surging Prevalence of Cardiac Diseases, Expensive Screening Process, Evolving Global Regulatory Requirements for HERG Screening, Heterogeneity in Testing Procedures, Preclinical Drug Development Market Expansion, AI and Machine Learning in HERG Screening, CRO Services to Grow, Insufficient Testing of Complex Drugs, Trade-off Between Speed and Accuracy.

Q3. What are the top players operating in the HERG Screening Market?

The major players in the market are Invitae Corporation, Thermo Fisher Scientific, F HoffmannLa Roche Ltd, Siemens Healthineers, Abbott Laboratories, Qiagen, BioRad Laboratories, Danaher Corporation, BD Becton Dickinson and Company, PerkinElmer, Agilent Technologies, Merck KGaA, Illumina, Sysmex Corporation, Quest Diagnostics, Laboratory Corporation of America Holdings LabCorp, BioTechne Corporation, GE Healthcare, Hologic Inc, Myriad Genetics

Q4. What segments are covered in the HERG Screening Market?

The Global HERG Screening Market is segmented based on Screening Type, End User, Technology, Application, and Geography.

About US:

Company information

(TrendBridge Insights is a premier global market research and consulting firm that provides comprehensive market intelligence, strategic insights, and data-driven solutions to businesses worldwide. With over 15 years of expertise across diverse industries, we help organizations make informed decisions that drive growth and competitive advantage.)

Contact US

Ganesh

Mail - info@trendbridgeinsights.com

Website Link-https://trendbridgeinsights.com/

Linkedin Page- https://www.linkedin.com/company/trend-bridge-insights/

Reference Links:

https://www.trendbridgeinsights.com/industry-report/celiac-disease-drug-market

https://www.trendbridgeinsights.com/industry-report/alcoholic-hepatitis-treatment-market

https://www.trendbridgeinsights.com/industry-report/rsv-vaccine-market

https://www.trendbridgeinsights.com/industry-report/antibiotics-market

https://www.trendbridgeinsights.com/industry-report/pancreatic-cancer-treatment-market

https://www.trendbridgeinsights.com/industry-report/joint-pain-injections-market